<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abnormal left ventricular (LV) systolic function is an independent risk factor for <z:hpo ids='HP_0001297'>stroke</z:hpo> in persons with <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="8" ids="10033">Warfarin</z:chebi> given in a dose to achieve an International Normalized Ratio (INR) between 2.0 and 3.0 or 2.5 to 4.0 (mean ratio 2.9) is more efficacious than aspirin in reducing the incidence of <z:hpo ids='HP_0001297'>stroke</z:hpo> in persons with <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This study reports on 36-month follow-up data from 350 older persons with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> showing the effect of <z:chebi fb="8" ids="10033">warfarin</z:chebi> versus aspirin on the incidence of new <z:hpo ids='HP_0001727'>thromboembolic stroke</z:hpo> in persons with abnormal and <z:mpath ids='MPATH_458'>normal</z:mpath> LV ejection fraction </plain></SENT>
</text></document>